Phase II trial of mitoxantrone in patients with hepatocellular carcinoma

Eur J Cancer Clin Oncol. 1988 Dec;24(12):1897-8. doi: 10.1016/0277-5379(88)90104-6.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Carcinoma, Hepatocellular / drug therapy*
  • Drug Evaluation
  • Female
  • Humans
  • Leukopenia / chemically induced
  • Liver Neoplasms / drug therapy*
  • Male
  • Middle Aged
  • Mitoxantrone / adverse effects
  • Mitoxantrone / therapeutic use*
  • Thrombocytopenia / chemically induced

Substances

  • Mitoxantrone